Clinical Trial

Hemiarch vs Extended Arch in Type 1 Aortic Dissection

Study acronym: HEADSTART
Recruiting
View on ClinicalTrials.gov →
Summary
HEADSTART is a prospective, open-label, non-blinded, multicenter, randomized controlled trial that compares a composite of mortality and re-intervention in patients undergoing hemiarch and extended arch repair for acute DeBakey type 1 aortic dissection. Eligible patients will be randomized to one or the other surgical strategy and clinical and imaging outcome data will be collected over a 3 year follow up period.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2019-03-19; most recent amendment 2025-09-17.
Status change: Not Yet Recruiting → Recruiting 2019-05-15
Trial Details
NCT Number NCT03885635
Lead Sponsor Ottawa Heart Institute Research Corporation
Conditions Aortic Dissection
Enrollment 50 participants
Start Date 2024-07-30
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-22